The Role and Therapeutic Potential of Melatonin in Degenerative Fundus Diseases: Diabetes Retinopathy and Age-Related Macular Degeneration

References

• Chen X, Rong SS, Xu Q, et al. Diabetes mellitus and risk of age-related macular degeneration: a systematic review and meta-analysis. PLoS One. 2014;9(9):e108196. doi:10.1371/journal.pone.0108196
   PubMed Web of Science ®Google Scholar
• Pascolini D, Mariotti SP, Pokharel GP, et al. 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol. 2004;11(2):67–115. doi:10.1076/opep.11.2.67.28158
   PubMed Web of Science ®Google Scholar
• Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–116. doi:10.1016/s2214-109x(13)70145-1
   PubMed Web of Science ®Google Scholar
• Heesterbeek TJ, Lorés-Motta L, Hoyng CB, Lechanteur YTE, den Hollander AI. Risk factors for progression of age-related macular degeneration. Ophthalmic Physiol Opt. 2020;40(2):140–170. doi:10.1111/opo.12675
   PubMed Web of Science ®Google Scholar
• Zisimopoulos A, Klavdianou O, Theodossiadis P, Chatziralli I. The role of the microbiome in age-related macular degeneration: a review of the literature. Ophthalmologica. 2021;244(3):173–178. doi:10.1159/000515026
   PubMed Web of Science ®Google Scholar
• Hernández-Zimbrón LF, Zamora-Alvarado R, Ochoa-de la paz L, et al. Age-related macular degeneration: new paradigms for treatment and management of AMD. Oxid Med Cell Longev. 2018;2018:8374647. doi:10.1155/2018/8374647
   PubMed Web of Science ®Google Scholar
• Das A. Diabetic retinopathy: battling the global epidemic. Indian J Ophthalmol. 2016;64(1):2–3. doi:10.4103/0301-4738.178155
   PubMed Web of Science ®Google Scholar
• Ting DS, Cheung GC, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44(4):260–277. doi:10.1111/ceo.12696
   PubMed Web of Science ®Google Scholar
• Bourouki E, Dimitriou E, Chatzipantelis A, et al. Co-existence of age-related macular degeneration and diabetic retinopathy in a tertiary referral center in Greece. Cureus. 2022;14(11):e31051. doi:10.7759/cureus.31051
   PubMed Web of Science ®Google Scholar
• Vasey C, McBride J, Penta K. Circadian rhythm dysregulation and restoration: the role of melatonin. Nutrients. 2021;13(10). doi:10.3390/nu13103480
   PubMed Web of Science ®Google Scholar
• Andrews CD, Foster RG, Alexander I, et al. Sleep-wake disturbance related to ocular disease: a systematic review of phase-shifting pharmaceutical therapies. Transl Vis Sci Technol. 2019;8(3):49. doi:10.1167/tvst.8.3.49
   PubMed Web of Science ®Google Scholar
• Rosen R, Hu DN, Perez V, et al. Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients. Mol Vis. 2009;15:1673–1679.
   PubMed Web of Science ®Google Scholar
• Schmid-Kubista KE, Glittenberg CG, Cezanne M, Holzmann K, Neumaier-Ammerer B, Binder S. Daytime levels of melatonin in patients with age-related macular degeneration. Acta Ophthalmol. 2009;87(1):89–93. doi:10.1111/j.1755-3768.2008.01173.x
   PubMed Web of Science ®Google Scholar
• Tang L, Zhang C, Lu L, et al. Melatonin maintains inner blood-retinal barrier by regulating microglia via inhibition of PI3K/Akt/Stat3/NF-κB signaling pathways in experimental diabetic retinopathy. Front Immunol. 2022;13:831660. doi:10.3389/fimmu.2022.831660
   PubMed Web of Science ®Google Scholar
• Bonnefond A, Clément N, Fawcett K, et al. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet. 2012;44(3):297–301. doi:10.1038/ng.1053
   PubMed Web of Science ®Google Scholar
• Li C, Shi Y, You L, Wang L, Chen ZJ. Melatonin receptor 1A gene polymorphism associated with polycystic ovary syndrome. Gynecol Obstet Invest. 2011;72(2):130–134. doi:10.1159/000323542
   PubMed Web of Science ®Google Scholar
• Mehrzadi S, Hemati K, Reiter RJ, Hosseinzadeh A. Mitochondrial dysfunction in age-related macular degeneration: melatonin as a potential treatment. Expert Opin Ther Targets. 2020;24(4):359–378. doi:10.1080/14728222.2020.1737015
   PubMed Web of Science ®Google Scholar
• Dehdashtian E, Mehrzadi S, Yousefi B, et al. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress. Life Sci. 2018;193:20–33. doi:10.1016/j.lfs.2017.12.001
   PubMed Web of Science ®Google Scholar
• Kaur C, Foulds WS, Ling EA. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res. 2008;27(6):622–647. doi:10.1016/j.preteyeres.2008.09.003
   PubMed Web of Science ®Google Scholar
• Buscemi N, Vandermeer B, Hooton N, et al. The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med. 2005;20(12):1151–1158. doi:10.1111/j.1525-1497.2005.0243.x
   PubMed Web of Science ®Google Scholar
• Costa EJ, Lopes RH, Lamy-Freund MT. Permeability of pure lipid bilayers to melatonin. J Pineal Res. 1995;19(3):123–126. doi:10.1111/j.1600-079x.1995.tb00180.x
   PubMed Web of Science ®Google Scholar
• Tosini G, Chaurasia SS, Michael Iuvone P. Regulation of arylalkylamine N-acetyltransferase (AANAT) in the retina. Chronobiol Int. 2006;23(1–2):381–391. doi:10.1080/07420520500482066
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Patel KK, Dehari D, Agrawal AK, Singh S. Melatonin and its ubiquitous anticancer effects. Mol Cell Biochem. 2019;462(1–2):133–155. doi:10.1007/s11010-019-03617-5
   PubMed Web of Science ®Google Scholar
• Claustrat B, Leston J. Melatonin: physiological effects in humans. Neurochirurgie. 2015;61(2–3):77–84. doi:10.1016/j.neuchi.2015.03.002
   PubMed Web of Science ®Google Scholar
• Tosini G, Baba K, Hwang CK, Iuvone PM. Melatonin: an underappreciated player in retinal physiology and pathophysiology. Exp Eye Res. 2012;103:82–89. doi:10.1016/j.exer.2012.08.009
   PubMed Web of Science ®Google Scholar
• Martínez A, Knappskog PM, Haavik J. A structural approach into human tryptophan hydroxylase and its implications for the regulation of serotonin biosynthesis. Curr Med Chem. 2001;8(9):1077–1091. doi:10.2174/0929867013372616
   PubMed Web of Science ®Google Scholar
• Hardeland R. Taxon- and site-specific melatonin catabolism. Molecules. 2017;22(11). doi:10.3390/molecules22112015
   PubMed Web of Science ®Google Scholar
• Bruni O, Angriman M, Melegari MG, Ferri R. Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders. Expert Opin Pharmacother. 2019;20(18):2257–2271. doi:10.1080/14656566.2019.1674283
   PubMed Web of Science ®Google Scholar
• Kurhaluk N, Tkachenko H. Melatonin and alcohol-related disorders. Chronobiol Int. 2020;37(6):781–803. doi:10.1080/07420528.2020.1761372
   PubMed Web of Science ®Google Scholar
• Jauhari A, Baranov SV, Suofu Y, et al. Melatonin inhibits cytosolic mitochondrial DNA-induced neuroinflammatory signaling in accelerated aging and neurodegeneration. J Clin Invest. 2020;130(6):3124–3136. doi:10.1172/jci135026
   PubMed Web of Science ®Google Scholar
• Brennan R, Jan JE, Lyons CJ. Light, dark, and melatonin: emerging evidence for the importance of melatonin in ocular physiology. Eye. 2007;21(7):901–908. doi:10.1038/sj.eye.6702597
   PubMed Web of Science ®Google Scholar
• Cipolla-Neto J, Amaral FGD. Melatonin as a hormone: new physiological and clinical insights. Endocr Rev. 2018;39(6):990–1028. doi:10.1210/er.2018-00084
   PubMed Web of Science ®Google Scholar
• Drijfhout WJ, Van der linde AG, Kooi SE, Grol CJ, Westerink BH. Norepinephrine release in the rat pineal gland: the input from the biological clock measured by in vivo microdialysis. J Neurochem. 1996;66(2):748–755. doi:10.1046/j.1471-4159.1996.66020748.x
   PubMed Web of Science ®Google Scholar
• Maronde E, Wicht H, Taskén K, et al. CREB phosphorylation and melatonin biosynthesis in the rat pineal gland: involvement of cyclic AMP dependent protein kinase type II. J Pineal Res. 1999;27(3):170–182. doi:10.1111/j.1600-079x.1999.tb00613.x
   PubMed Web of Science ®Google Scholar
• Shin JW. Neuroprotective effects of melatonin in neurodegenerative and autoimmune central nervous system diseases. Encephalitis. 2023;3(2):44–53. doi:10.47936/encephalitis.2022.00094
   PubMedGoogle Scholar
• Polyakova VO, Kvetnoy IM, Anderson G, Rosati J, Mazzoccoli G, Linkova NS. Reciprocal interactions of mitochondria and the neuroimmunoendocrine system in neurodegenerative disorders: an important role for melatonin regulation. Front Physiol. 2018;9:199. doi:10.3389/fphys.2018.00199
   PubMed Web of Science ®Google Scholar
• Masters A, Pandi-Perumal SR, Seixas A, Girardin JL, McFarlane SI. Melatonin, the hormone of darkness: from sleep promotion to Ebola treatment. Brain Disord Ther. 2014;4(1). doi:10.4172/2168-975x.1000151
   PubMedGoogle Scholar
• Huang CC, Chiou CH, Liu SC, et al. Melatonin attenuates TNF-α and IL-1β expression in synovial fibroblasts and diminishes cartilage degradation: implications for the treatment of rheumatoid arthritis. J Pineal Res. 2019;66(3):e12560. doi:10.1111/jpi.12560
   PubMed Web of Science ®Google Scholar
• Watanabe K, Araki M, Iwasaki H. The embryonic pineal body as a multipotent organ. Microsc Res Tech. 1992;21(3):218–226. doi:10.1002/jemt.1070210305
   PubMed Web of Science ®Google Scholar
• Pires-Lapa MA, Carvalho-Sousa CE, Cecon E, Fernandes PA, Markus RP. β-adrenoceptors trigger melatonin synthesis in phagocytes. Int J Mol Sci. 2018;19(8). doi:10.3390/ijms19082182
   PubMed Web of Science ®Google Scholar
• Won E, Na KS, Kim YK. Associations between melatonin, neuroinflammation, and brain alterations in depression. Int J Mol Sci. 2021;23(1). doi:10.3390/ijms23010305
   Web of Science ®Google Scholar
• Simonneaux V, Ribelayga C. Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev. 2003;55(2):325–395. doi:10.1124/pr.55.2.2
   PubMed Web of Science ®Google Scholar
• Aykan U, Güvel M, Paykal G, Uluoglu C. Neuropharmacologic modulation of the melatonergic system. Explorat Neurosci. 2023;2:287–306. doi:10.37349/en.2023.00029
   Google Scholar
• Provencio I, Rodriguez IR, Jiang G, Hayes WP, Moreira EF, Rollag MD. A novel human opsin in the inner retina. J Neurosci. 2000;20(2):600–605. doi:10.1523/jneurosci.20-02-00600.2000
   PubMed Web of Science ®Google Scholar
• Abbott KS, Queener HM, Ostrin LA. The ipRGC-driven pupil response with light exposure, refractive error, and sleep. Optom Vis Sci. 2018;95(4):323–331. doi:10.1097/opx.0000000000001198
   PubMed Web of Science ®Google Scholar
• Zawilska JB, Nowak JZ. Regulatory mechanisms in melatonin biosynthesis in retina. Neurochem Int. 1992;20(1):23–36. doi:10.1016/0197-0186(92)90122-8
   PubMed Web of Science ®Google Scholar
• Fujieda H, Scher J, Hamadanizadeh SA, Wankiewicz E, Pang SF, Brown GM. Dopaminergic and GABAergic amacrine cells are direct targets of melatonin: immunocytochemical study of mt1 melatonin receptor in Guinea pig retina. Vis Neurosci. 2000;17(1):63–70. doi:10.1017/s0952523800171068
   PubMed Web of Science ®Google Scholar
• Emet M, Ozcan H, Ozel L, Yayla M, Halici Z, Hacimuftuoglu A. A review of melatonin, its receptors and drugs. Eurasian J Med. 2016;48(2):135–141. doi:10.5152/eurasianjmed.2015.0267
   PubMedGoogle Scholar
• Gianesini C, Hiragaki S, Laurent V, Hicks D, Tosini G. Cone viability is affected by disruption of melatonin receptors signaling. Invest Ophthalmol Vis Sci. 2016;57(1):94–104. doi:10.1167/iovs.15-18235
   PubMed Web of Science ®Google Scholar
• Rosen RB, Hu DN, Chen M, McCormick SA, Walsh J, Roberts JE. Effects of melatonin and its receptor antagonist on retinal pigment epithelial cells against hydrogen peroxide damage. Mol Vis. 2012;18:1640–1648.
   PubMed Web of Science ®Google Scholar
• Liang FQ, Green L, Wang C, Alssadi R, Godley BF. Melatonin protects human retinal pigment epithelial (RPE) cells against oxidative stress. Exp Eye Res. 2004;78(6):1069–1075. doi:10.1016/j.exer.2004.02.003
   PubMed Web of Science ®Google Scholar
• Boatright JH, Rubim NM, Iuvone PM. Regulation of endogenous dopamine release in amphibian retina by melatonin: the role of GABA. Vis Neurosci. 1994;11(5):1013–1018. doi:10.1017/s0952523800003941
   PubMed Web of Science ®Google Scholar
• Scher J, Wankiewicz E, Brown GM, Fujieda H. AII amacrine cells express the MT1 melatonin receptor in human and macaque retina. Exp Eye Res. 2003;77(3):375–382. doi:10.1016/s0014-4835(03)00123-4
   PubMed Web of Science ®Google Scholar
• Ivanova TN, Alonso-Gomez AL, Iuvone PM. Dopamine D4 receptors regulate intracellular calcium concentration in cultured chicken cone photoreceptor cells: relationship to dopamine receptor-mediated inhibition of cAMP formation. Brain Res. 2008;1207:111–119. doi:10.1016/j.brainres.2008.02.025
   PubMed Web of Science ®Google Scholar
• Fukuhara PS, Lee DH, Chwa M, Kuppermann BD, Kenney MC. Effects of melatonin on human Retinal Pigment Epithelial cells (ARPE-19) and Müller cells (MIO-M1) exposed to cobalt chloride (CoCl2) in vitro. Invest Ophthalmol Visual Sci. 2021;62(8):2722.
   Web of Science ®Google Scholar
• Laurent V, Sengupta A, Sánchez-Bretaño A, Hicks D, Tosini G. Melatonin signaling affects the timing in the daily rhythm of phagocytic activity by the retinal pigment epithelium. Exp Eye Res. 2017;165:90–95. doi:10.1016/j.exer.2017.09.007
   PubMed Web of Science ®Google Scholar
• Wiechmann AF, Yang XL, Wu SM, Hollyfield JG. Melatonin enhances horizontal cell sensitivity in salamander retina. Brain Res. 1988;453(1–2):377–380. doi:10.1016/0006-8993(88)90182-5
   PubMed Web of Science ®Google Scholar
• Yu HS, Hernandez V, Haywood M, Wong CG. Melatonin inhibits the proliferation of retinal pigment epithelial (RPE) cells in vitro. In Vitro Cell Dev Biol Anim. 1993;29a(5):415–418. doi:10.1007/bf02633991
   PubMed Web of Science ®Google Scholar
• Hagström A, Kal Omar R, Williams PA, Stålhammar G. The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature. BMC Cancer. 2022;22(1):398. doi:10.1186/s12885-022-09464-w
   PubMed Web of Science ®Google Scholar
• Kal Omar R, Hagström A, Stålhammar G. Adjuvant melatonin for uveal melanoma (AMUM): protocol for a randomized open-label phase III study. Trials. 2023;24(1):230. doi:10.1186/s13063-023-07245-9
   PubMed Web of Science ®Google Scholar
• Roberts JE, Wiechmann AF, Hu DN. Melatonin receptors in human uveal melanocytes and melanoma cells. J Pineal Res. 2000;28(3):165–171. doi:10.1034/j.1600-079x.2001.280306.x
   PubMed Web of Science ®Google Scholar
• Ku LC, Sheu ML, Cheng HH, et al. Melatonin protects retinal integrity through mediated immune homeostasis in the sodium iodate-induced mouse model of age-related macular degeneration. Biomed Pharmacother. 2023;161:114476. doi:10.1016/j.biopha.2023.114476
   PubMed Web of Science ®Google Scholar
• Wiechmann AF, Udin SB, Summers Rada JA. Localization of Mel1b melatonin receptor-like immunoreactivity in ocular tissues of Xenopus laevis. Exp Eye Res. 2004;79(4):585–594. doi:10.1016/j.exer.2004.07.004
   PubMed Web of Science ®Google Scholar
• Wang F, Zhou J, Lu Y, Chu R. Effects of 530 nm green light on refractive status, melatonin, MT1 receptor, and melanopsin in the Guinea pig. Curr Eye Res. 2011;36(2):103–111. doi:10.3109/02713683.2010.526750
   PubMed Web of Science ®Google Scholar
• Zheng W, Chen Y, Zhou X, et al. Regulation of retinal melanopsin on lens-induced myopia in Guinea Pigs. Optom Vis Sci. 2020;97(7):489–495. doi:10.1097/opx.0000000000001529
   PubMed Web of Science ®Google Scholar
• Alkozi HA, Wang X, Perez de Lara MJ, Pintor J. Presence of melanopsin in human crystalline lens epithelial cells and its role in melatonin synthesis. Exp Eye Res. 2017;154:168–176. doi:10.1016/j.exer.2016.11.019
   PubMed Web of Science ®Google Scholar
• Alkozi HA, Perez de Lara MJ, Sánchez-Naves J, Pintor J. TRPV4 stimulation induced melatonin secretion by increasing Arylalkymine N-acetyltransferase (AANAT) protein level. Int J Mol Sci. 2017;18(4). doi:10.3390/ijms18040746
   PubMed Web of Science ®Google Scholar
• Spadea L, Maraone G, Verboschi F, Vingolo EM, Tognetto D. Effect of corneal light scatter on vision: a review of the literature. Int J Ophthalmol. 2016;9(3):459–464. doi:10.18240/ijo.2016.03.24
   PubMed Web of Science ®Google Scholar
• Kiliç A, Selek S, Erel O, Aksoy N. Protective effects of melatonin on oxidative-antioxidative balance and cataract formation in rats. Ann Ophthalmol. 2008;40(1):22–27.
   Google Scholar
• Anwar MM, Moustafa MA. The effect of melatonin on eye lens of rats exposed to ultraviolet radiation. Comp Biochem Physiol C Toxicol Pharmacol. 2001;129(1):57–63. doi:10.1016/s1532-0456(01)00180-6
   PubMed Web of Science ®Google Scholar
• Lledó VE, Alkozi HA, Sánchez-Naves J, Fernandez-Torres MA, Guzman-Aranguez A. Melatonin counteracts oxidative damage in lens by regulation of Nrf2 and NLRP3 inflammasome activity. Exp Eye Res. 2022;215:108912. doi:10.1016/j.exer.2021.108912
   PubMed Web of Science ®Google Scholar
• Li C, Tian Y, Yao A, Zha X, Zhang J, Tao Y. Intravitreal delivery of melatonin is protective against the photoreceptor loss in mice: a potential therapeutic strategy for degenerative retinopathy. Front Pharmacol. 2019;10:1633. doi:10.3389/fphar.2019.01633
   PubMed Web of Science ®Google Scholar
• Martin XD, Malina HZ, Brennan MC, Hendrickson PH, Lichter PR. The ciliary body--The third organ found to synthesize indoleamines in humans. Eur J Ophthalmol. 1992;2(2):67–72. doi:10.1177/112067219200200203
   PubMedGoogle Scholar
• Chiquet C, Claustrat B, Thuret G, Brun J, Cooper HM, Denis P. Melatonin concentrations in aqueous humor of glaucoma patients. Am J Ophthalmol. 2006;142(2):325–327.e321. doi:10.1016/j.ajo.2006.03.040
   PubMed Web of Science ®Google Scholar
• Alkozi H, Sánchez-Naves J, de Lara MJ, et al. Elevated intraocular pressure increases melatonin levels in the aqueous humour. Acta Ophthalmol. 2017;95(3):e185–e189. doi:10.1111/aos.13253
   PubMed Web of Science ®Google Scholar
• Pintor J, Martin L, Pelaez T, Hoyle CH, Peral A. Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits. Eur J Pharmacol. 2001;416(3):251–254. doi:10.1016/s0014-2999(01)00864-0
   PubMed Web of Science ®Google Scholar
• Andrés-Guerrero V, Molina-Martínez IT, Peral A, de Las Heras B, Pintor J, Herrero-Vanrell R. The use of mucoadhesive polymers to enhance the hypotensive effect of a melatonin analogue, 5-MCA-NAT, in rabbit eyes. Invest Ophthalmol Vis Sci. 2011;52(3):1507–1515. doi:10.1167/iovs.10-6099
   PubMed Web of Science ®Google Scholar
• Huete-Toral F, Crooke A, Martínez-águila A, Pintor J. Melatonin receptors trigger cAMP production and inhibit chloride movements in nonpigmented ciliary epithelial cells. J Pharmacol Exp Ther. 2015;352(1):119–128. doi:10.1124/jpet.114.218263
   PubMed Web of Science ®Google Scholar
• Rosenstein RE, Pandi-Perumal SR, Srinivasan V, Spence DW, Brown GM, Cardinali DP. Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis. J Pineal Res. 2010;49(1):1–13. doi:10.1111/j.1600-079X.2010.00764.x
   PubMed Web of Science ®Google Scholar
• Gao J, Provencio I, Liu X. Intrinsically photosensitive retinal ganglion cells in glaucoma. Front Cell Neurosci. 2022;16:992747. doi:10.3389/fncel.2022.992747
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang Y, Ding J, Wang N. Changes in the circadian rhythm in patients with primary glaucoma. PLoS One. 2013;8(4):e62841. doi:10.1371/journal.pone.0062841
   PubMed Web of Science ®Google Scholar
• Crooke A, Guzman-Aranguez A, Mediero A, et al. Effect of melatonin and analogues on corneal wound healing: involvement of Mt2 melatonin receptor. Curr Eye Res. 2015;40(1):56–65. doi:10.3109/02713683.2014.914540
   PubMed Web of Science ®Google Scholar
• Wiechmann AF, Hollaway LR, Rada JA. Melatonin receptor expression in Xenopus laevis surface corneal epithelium: diurnal rhythm of lateral membrane localization. Mol Vis. 2009;15:2384–2403.
   PubMed Web of Science ®Google Scholar
• Wahl C, Li T, Takagi Y, Howland H. The effects of light regimes and hormones on corneal growth in vivo and in organ culture. J Anat. 2011;219(6):766–775. doi:10.1111/j.1469-7580.2011.01429.x
   PubMed Web of Science ®Google Scholar
• Sasaki M, Masuda A, Oishi T. Circadian rhythms of corneal mitotic rate, retinal melatonin and immunoreactive visual pigments, and the effects of melatonin on the rhythms in the Japanese quail. J Comp Physiol A. 1995;176(4):465–471. doi:10.1007/bf00196412
   PubMed Web of Science ®Google Scholar
• Ciuffi M, Pisanello M, Pagliai G, et al. Antioxidant protection in cultured corneal cells and whole corneas submitted to UV-B exposure. J Photochem Photobiol B. 2003;71(1–3):59–68. doi:10.1016/j.jphotobiol.2003.07.004
   PubMed Web of Science ®Google Scholar
• Rusciano D, Russo C. The therapeutic trip of melatonin eye drops: from the ocular surface to the retina. Pharmaceuticals. 2024;17(4). doi:10.3390/ph17040441
   Web of Science ®Google Scholar
• Nopparat C, Chaopae W, Boontem P, Sopha P, Wongchitrat P, Govitrapong P. Melatonin attenuates high glucose-induced changes in beta amyloid precursor protein processing in human neuroblastoma cells. Neurochem Res. 2022;47(9):2568–2579. doi:10.1007/s11064-021-03290-5
   PubMed Web of Science ®Google Scholar
• Chang CC, Huang TY, Chen HY, et al. Protective effect of melatonin against oxidative stress-induced apoptosis and enhanced autophagy in human retinal pigment epithelium cells. Oxid Med Cell Longev. 2018;2018:9015765. doi:10.1155/2018/9015765
   PubMed Web of Science ®Google Scholar
• Jung KH, Hong SW, Zheng HM, et al. Melatonin ameliorates cerulein-induced pancreatitis by the modulation of nuclear erythroid 2-related factor 2 and nuclear factor-kappaB in rats. J Pineal Res. 2010;48(3):239–250. doi:10.1111/j.1600-079X.2010.00748.x
   PubMed Web of Science ®Google Scholar
• Jung KH, Hong SW, Zheng HM, Lee DH, Hong SS. Melatonin downregulates nuclear erythroid 2-related factor 2 and nuclear factor-kappaB during prevention of oxidative liver injury in a dimethylnitrosamine model. J Pineal Res. 2009;47(2):173–183. doi:10.1111/j.1600-079X.2009.00698.x
   PubMed Web of Science ®Google Scholar
• Jiang T, Chang Q, Cai J, Fan J, Zhang X, Xu G. Protective effects of melatonin on retinal inflammation and oxidative stress in experimental diabetic retinopathy. Oxid Med Cell Longev. 2016;2016:3528274. doi:10.1155/2016/3528274
   PubMed Web of Science ®Google Scholar
• Jiang T, Chang Q, Zhao Z, et al. Melatonin-mediated cytoprotection against hyperglycemic injury in Müller cells. PLoS One. 2012;7(12):e50661. doi:10.1371/journal.pone.0050661
   PubMed Web of Science ®Google Scholar
• Xie M, Hu A, Luo Y, Sun W, Hu X, Tang S. Interleukin-4 and melatonin ameliorate high glucose and interleukin-1β stimulated inflammatory reaction in human retinal endothelial cells and retinal pigment epithelial cells. Mol Vis. 2014;20:921–928.
   PubMed Web of Science ®Google Scholar
• Do Carmo Buonfiglio D, Peliciari-Garcia RA, Do Amaral FG, et al. Early-stage retinal melatonin synthesis impairment in streptozotocin-induced diabetic Wistar rats. Invest Ophthalmol Vis Sci. 2011;52(10):7416–7422. doi:10.1167/iovs.10-6756
   PubMed Web of Science ®Google Scholar
• Chen H, Liu X, Zhu W, et al. SIRT1 ameliorates age-related senescence of mesenchymal stem cells via modulating telomere shelterin. Front Aging Neurosci. 2014;6:103. doi:10.3389/fnagi.2014.00103
   PubMed Web of Science ®Google Scholar
• Hikichi T, Tateda N, Miura T. Alteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy. Clin Ophthalmol. 2011;5:655–660. doi:10.2147/opth.S19559
   PubMedGoogle Scholar
• Fu Y, Tang M, Fan Y, Zou H, Sun X, Xu X. Anti-apoptotic effects of melatonin in retinal pigment epithelial cells. Front Biosci. 2012;17(4):1461–1468. doi:10.2741/3997
   Google Scholar
• Liang FQ, Aleman TS, ZaixinYang CAV, Jacobson SG, Bennett J. Melatonin delays photoreceptor degeneration in the rds/rds mouse. Neuroreport. 2001;12(5):1011–1014. doi:10.1097/00001756-200104170-00029
   PubMed Web of Science ®Google Scholar
• Flynn-Evans EE, Tabandeh H, Skene DJ, Lockley SW. Circadian rhythm disorders and melatonin production in 127 blind women with and without light perception. J Biol Rhythms. 2014;29(3):215–224. doi:10.1177/0748730414536852
   PubMed Web of Science ®Google Scholar
• Tokarz P, Piastowska-Ciesielska AW, Kaarniranta K, Blasiak J. All-trans retinoic acid modulates DNA damage response and the expression of the VEGF-A and MKI67 genes in ARPE-19 cells subjected to oxidative stress. Int J Mol Sci. 2016;17(6). doi:10.3390/ijms17060898
   PubMed Web of Science ®Google Scholar
• Tokarz P, Kaarniranta K, Blasiak J. Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD). Biogerontology. 2013;14(5):461–482. doi:10.1007/s10522-013-9463-2
   PubMed Web of Science ®Google Scholar
• Honda S, Hjelmeland LM, Handa JT. Oxidative stress--induced single-strand breaks in chromosomal telomeres of human retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci. 2001;42(9):2139–2144.
   PubMed Web of Science ®Google Scholar
• Lau BW, Tsao GS, So KF, Yip HK. Expression of telomerase reverse transcriptase in adult goldfish retina. J Mol Neurosci. 2007;32(2):160–167. doi:10.1007/s12031-007-0031-6
   PubMed Web of Science ®Google Scholar
• Blasiak J, Reiter RJ, Kaarniranta K. Melatonin in retinal physiology and pathology: the case of age-related macular degeneration. Oxid Med Cell Longev. 2016;2016:6819736. doi:10.1155/2016/6819736
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Mayo JC, Tan DX, Sainz RM, Alatorre-Jimenez M, Qin L. Melatonin as an antioxidant: under promises but over delivers. J Pineal Res. 2016;61(3):253–278. doi:10.1111/jpi.12360
   PubMed Web of Science ®Google Scholar
• Aranda ML, Fleitas MFG, Dieguez H, et al. Melatonin as a therapeutic resource for inflammatory visual diseases. Curr Neuropharmacol. 2017;15(7):951–962. doi:10.2174/1570159x15666170113122120
   PubMed Web of Science ®Google Scholar
• Korkmaz A, Reiter RJ, Topal T, Manchester LC, Oter S, Tan DX. Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med. 2009;15(1–2):43–50. doi:10.2119/molmed.2008.00117
   PubMed Web of Science ®Google Scholar
• Siu AW, Reiter RJ, To CH. Pineal indoleamines and vitamin E reduce nitric oxide-induced lipid peroxidation in rat retinal homogenates. J Pineal Res. 1999;27(2):122–128. doi:10.1111/j.1600-079x.1999.tb00606.x
   PubMed Web of Science ®Google Scholar
• Tan DX, Manchester LC, Esteban-Zubero E, Zhou Z, Reiter RJ. Melatonin as a potent and inducible endogenous antioxidant: synthesis and metabolism. Molecules. 2015;20(10):18886–18906. doi:10.3390/molecules201018886
   PubMed Web of Science ®Google Scholar
• Bardak H, Uğuz AC, Bardak Y. Protective effects of melatonin and memantine in human retinal pigment epithelium (ARPE-19) cells against 2-ethylpyridine-induced oxidative stress: implications for age-related macular degeneration. Cutan Ocul Toxicol. 2018;37(2):112–120. doi:10.1080/15569527.2017.1354218
   PubMed Web of Science ®Google Scholar
• Yilmaz T, Celebi S, Kükner AS. The protective effects of melatonin, vitamin E and octreotide on retinal edema during ischemia-reperfusion in the Guinea pig retina. Eur J Ophthalmol. 2002;12(6):443–449. doi:10.1177/112067210201200601
   PubMed Web of Science ®Google Scholar
• Karunadharma PP, Nordgaard CL, Olsen TW, Ferrington DA. Mitochondrial DNA damage as a potential mechanism for age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010;51(11):5470–5479. doi:10.1167/iovs.10-5429
   PubMed Web of Science ®Google Scholar
• Ramis MR, Esteban S, Miralles A, Tan DX, Reiter RJ. Protective effects of melatonin and mitochondria-targeted antioxidants against oxidative stress: a review. Curr Med Chem. 2015;22(22):2690–2711. doi:10.2174/0929867322666150619104143
   PubMed Web of Science ®Google Scholar
• Bonilla E, Valero N, Chacín-Bonilla L, et al. Melatonin increases interleukin-1beta and decreases tumor necrosis factor alpha in the brain of mice infected with the Venezuelan equine encephalomyelitis virus. Neurochem Res. 2003;28(5):681–686. doi:10.1023/a:1022897314108
   PubMed Web of Science ®Google Scholar
• Manchester LC, Coto-Montes A, Boga JA, et al. Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J Pineal Res. 2015;59(4):403–419. doi:10.1111/jpi.12267
   PubMed Web of Science ®Google Scholar
• Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res. 2007;2007:95103. doi:10.1155/2007/95103
   PubMed Web of Science ®Google Scholar
• Wang L, He C. Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis. Front Immunol. 2022;13:967193. doi:10.3389/fimmu.2022.967193
   PubMed Web of Science ®Google Scholar
• Bang J, Chang HW, Jung HR, et al. Melatonin attenuates clock gene cryptochrome1, which may aggravate mouse anti-type II collagen antibody-induced arthritis. Rheumatol Int. 2012;32(2):379–385. doi:10.1007/s00296-010-1641-9
   PubMed Web of Science ®Google Scholar
• Colombo J, Jardim-Perassi BV, Ferreira JPS, et al. Melatonin differentially modulates NF-кB expression in breast and liver cancer cells. Anticancer Agents Med Chem. 2018;18(12):1688–1694. doi:10.2174/1871520618666180131112304
   PubMed Web of Science ®Google Scholar
• Muxel SM, Pires-Lapa MA, Monteiro AW, et al. NF-κB drives the synthesis of melatonin in RAW 264.7 macrophages by inducing the transcription of the arylalkylamine-N-acetyltransferase (AA-NAT) gene. PLoS One. 2012;7(12):e52010. doi:10.1371/journal.pone.0052010
   PubMed Web of Science ®Google Scholar
• Li SJ, Cheng WL, Kao YH, Chung CC, Trang NN, Chen YJ. Melatonin inhibits NF-κB/CREB/Runx2 signaling and alleviates aortic valve calcification. Front Cardiovasc Med. 2022;9:885293. doi:10.3389/fcvm.2022.885293
   PubMed Web of Science ®Google Scholar
• Mihanfar A, Yousefi B, Azizzadeh B, Majidinia M. Interactions of melatonin with various signaling pathways: implications for cancer therapy. Cancer Cell Int. 2022;22(1):420. doi:10.1186/s12935-022-02825-2
   PubMed Web of Science ®Google Scholar
• Chen F, Liu H, Wang X, et al. Melatonin activates autophagy via the NF-κB signaling pathway to prevent extracellular matrix degeneration in intervertebral disc. Osteoarthritis Cartilage. 2020;28(8):1121–1132. doi:10.1016/j.joca.2020.05.011
   PubMed Web of Science ®Google Scholar
• Xia Y, Chen S, Zeng S, et al. Melatonin in macrophage biology: current understanding and future perspectives. J Pineal Res. 2019;66(2):e12547. doi:10.1111/jpi.12547
   PubMed Web of Science ®Google Scholar
• Qin T, Feng D, Zhou B, et al. Melatonin attenuates lipopolysaccharide-induced immune dysfunction in dendritic cells. Int Immunopharmacol. 2023;120:110282. doi:10.1016/j.intimp.2023.110282
   PubMed Web of Science ®Google Scholar
• Abd-Elhafeez HH, Hassan AHS, Hussein MT. Melatonin administration provokes the activity of dendritic reticular cells in the seminal vesicle of Soay ram during the non-breeding season. Sci Rep. 2021;11(1):872. doi:10.1038/s41598-020-79529-y
   PubMed Web of Science ®Google Scholar
• Lin LW, Wang SW, Huang WC, et al. Melatonin inhibits VEGF-induced endothelial progenitor cell angiogenesis in neovascular age-related macular degeneration. Cells. 2023;12(5). doi:10.3390/cells12050799
   Web of Science ®Google Scholar
• Zhu Z, Peng R, Shen H, et al. Treatment with melatonin after corneal graft attenuates rejection. Front Pharmacol. 2021;12:778892. doi:10.3389/fphar.2021.778892
   PubMed Web of Science ®Google Scholar
• Macchi MM, Bruce JN. Human pineal physiology and functional significance of melatonin. Front Neuroendocrinol. 2004;25(3–4):177–195. doi:10.1016/j.yfrne.2004.08.001
   PubMed Web of Science ®Google Scholar
• Osborne NN, Nash MS, Wood JP. Melatonin counteracts ischemia-induced apoptosis in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1998;39(12):2374–2383.
   PubMed Web of Science ®Google Scholar
• Tang L, Zhang C, Yang Q, et al. Melatonin maintains inner blood-retinal barrier via inhibition of p38/TXNIP/NF-κB pathway in diabetic retinopathy. J Cell Physiol. 2021;236(8):5848–5864. doi:10.1002/jcp.30269
   PubMed Web of Science ®Google Scholar
• Huang R, Xu Y, Lu X, et al. Melatonin protects inner retinal neurons of newborn mice after hypoxia-ischemia. J Pineal Res. 2021;71(1):e12716. doi:10.1111/jpi.12716
   PubMed Web of Science ®Google Scholar
• Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M. Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes. 2002;51(7):2241–2248. doi:10.2337/diabetes.51.7.2241
   PubMed Web of Science ®Google Scholar
• Qin T, Feng D, Zhou B, Bai L, Yin Y. Melatonin suppresses LPS-induced oxidative stress in dendritic cells for inflammatory regulation via the Nrf2/HO-1 axis. Antioxidants. 2022;11(10). doi:10.3390/antiox11102012
   Web of Science ®Google Scholar
• Zheng B, Meng J, Zhu Y, Ding M, Zhang Y, Zhou J. Melatonin enhances SIRT1 to ameliorate mitochondrial membrane damage by activating PDK1/Akt in granulosa cells of PCOS. J Ovarian Res. 2021;14(1):152. doi:10.1186/s13048-021-00912-y
   PubMed Web of Science ®Google Scholar
• Klettner A, Kampers M, Töbelmann D, Roider J, Dittmar M. The Influence of melatonin and light on VEGF secretion in primary RPE cells. Biomolecules. 2021;11(1). doi:10.3390/biom11010114
   PubMed Web of Science ®Google Scholar
• Yang L, Zhang Y, Ma Y, et al. Effect of melatonin on EGF- and VEGF-induced monolayer permeability of HUVECs. Am J Physiol Heart Circ Physiol. 2019;316(5):H1178–H1191. doi:10.1152/ajpheart.00542.2018
   PubMed Web of Science ®Google Scholar
• Choudhary P, Roy T, Chatterjee A, Mishra VK, Pant S, Swarnakar S. Melatonin rescues swim stress induced gastric ulceration by inhibiting matrix metalloproteinase-3 via down-regulation of inflammatory signaling cascade. Life Sci. 2022;297:120426. doi:10.1016/j.lfs.2022.120426
   PubMed Web of Science ®Google Scholar
• Wiechmann AF, Smith AR. Melatonin receptor RNA is expressed in photoreceptors and displays a diurnal rhythm in Xenopus retina. Brain Res Mol Brain Res. 2001;91(1–2):104–111. doi:10.1016/s0169-328x(01)00134-6
   PubMedGoogle Scholar
• Ostrin LA. Ocular and systemic melatonin and the influence of light exposure. Clin Exp Optom. 2019;102(2):99–108. doi:10.1111/cxo.12824
   PubMed Web of Science ®Google Scholar
• Luo N, Wang Y, Ma Y, Liu Y, Liu Z. Melatonin alleviates renal injury in diabetic rats by regulating autophagy. Mol Med Rep. 2023;28(5). doi:10.3892/mmr.2023.13101
   Web of Science ®Google Scholar
• Xu Y, Lu X, Hu Y, et al. Melatonin attenuated retinal neovascularization and neuroglial dysfunction by inhibition of HIF-1α-VEGF pathway in oxygen-induced retinopathy mice. J Pineal Res. 2018;64(4):e12473. doi:10.1111/jpi.12473
   PubMed Web of Science ®Google Scholar
• Xu Y, Cui K, Li J, et al. Melatonin attenuates choroidal neovascularization by regulating macrophage/microglia polarization via inhibition of RhoA/ROCK signaling pathway. J Pineal Res. 2020;69(1):e12660. doi:10.1111/jpi.12660
   PubMed Web of Science ®Google Scholar
• Masana MI, Doolen S, Ersahin C, et al. MT(2) melatonin receptors are present and functional in rat caudal artery. J Pharmacol Exp Ther. 2002;302(3):1295–1302. doi:10.1124/jpet.302.3.1295
   PubMed Web of Science ®Google Scholar
• Ting N, Thambyraja A, Sugden D, Scalbert E, Delagrange P, Wilson VG. Pharmacological studies on the inhibitory action of melatonin and putative melatonin analogues on porcine vascular smooth muscle. Naunyn Schmiedebergs Arch Pharmacol. 2000;361(3):327–333. doi:10.1007/s002109900198
   PubMed Web of Science ®Google Scholar
• Vandeputte C, Giummelly P, Atkinson J, Delagrange P, Scalbert E, Capdeville-Atkinson C. Melatonin potentiates NE-induced vasoconstriction without augmenting cytosolic calcium concentration. Am J Physiol Heart Circ Physiol. 2001;280(1):H420–H425. doi:10.1152/ajpheart.2001.280.1.H420
   PubMed Web of Science ®Google Scholar
• Meyer P, Pache M, Loeffler KU, et al. Melatonin MT-1-receptor immunoreactivity in the human eye. Br J Ophthalmol. 2002;86(9):1053–1057. doi:10.1136/bjo.86.9.1053
   PubMed Web of Science ®Google Scholar
• Savaskan E, Olivieri G, Brydon L, et al. Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer’s disease. Neurosci Lett. 2001;308(1):9–12. doi:10.1016/s0304-3940(01)01967-x
   PubMed Web of Science ®Google Scholar
• Doolen S, Krause DN, Dubocovich ML, Duckles SP. Melatonin mediates two distinct responses in vascular smooth muscle. Eur J Pharmacol. 1998;345(1):67–69. doi:10.1016/s0014-2999(98)00064-8
   PubMed Web of Science ®Google Scholar
• Trinh M, Kalloniatis M, Nivison-Smith L. Vascular changes in intermediate age-related macular degeneration quantified using optical coherence tomography angiography. Transl Vis Sci Technol. 2019;8(4):20. doi:10.1167/tvst.8.4.20
   PubMed Web of Science ®Google Scholar
• Ueno Y, Iwase T, Goto K, et al. Association of changes of retinal vessels diameter with ocular blood flow in eyes with diabetic retinopathy. Sci Rep. 2021;11(1):4653. doi:10.1038/s41598-021-84067-2
   PubMed Web of Science ®Google Scholar
• Arangino S, Cagnacci A, Angiolucci M, et al. Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol. 1999;83(9):1417–1419. doi:10.1016/s0002-9149(99)00112-5
   PubMed Web of Science ®Google Scholar
• Ray CA. Melatonin attenuates the sympathetic nerve responses to orthostatic stress in humans. J Physiol. 2003;551(Pt 3):1043–1048. doi:10.1113/jphysiol.2003.043182
   PubMed Web of Science ®Google Scholar
• Forsling ML, Wheeler MJ, Williams AJ. The effect of melatonin administration on pituitary hormone secretion in man. Clin Endocrinol. 1999;51(5):637–642. doi:10.1046/j.1365-2265.1999.00820.x
   PubMed Web of Science ®Google Scholar
• Yan M, Wang H, Gu Y, Li X, Tao L, Lu P. Melatonin exerts protective effects on diabetic retinopathy via inhibition of Wnt/β-catenin pathway as revealed by quantitative proteomics. Exp Eye Res. 2021;205:108521. doi:10.1016/j.exer.2021.108521
   PubMed Web of Science ®Google Scholar
• Ramezani M, Komaki A, Hashemi-Firouzi N, Mortezaee K, Faraji N, Golipoor Z. Therapeutic effects of melatonin-treated bone marrow mesenchymal stem cells (BMSC) in a rat model of Alzheimer’s disease. J Chem Neuroanat. 2020;108:101804. doi:10.1016/j.jchemneu.2020.101804
   PubMed Web of Science ®Google Scholar
• Yoon YM, Lee JH, Song KH, Noh H, Lee SH. Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease-derived mesenchymal stem/stromal cells via cellular prion proteins. J Pineal Res. 2020;68(3):e12632. doi:10.1111/jpi.12632
   PubMed Web of Science ®Google Scholar
• Lin Y, Ren X, Chen Y, Chen D. Interaction between mesenchymal stem cells and retinal degenerative microenvironment. Front Neurosci. 2020;14:617377. doi:10.3389/fnins.2020.617377
   PubMed Web of Science ®Google Scholar
• Salih M, Shaharuddin B, Abdelrazeg S. A concise review on mesenchymal stem cells for tissue engineering with a perspective on ocular surface regeneration. Curr Stem Cell Res Ther. 2020;15(3):211–218. doi:10.2174/1574888x15666200129145251
   PubMed Web of Science ®Google Scholar
• Madelaine R, Mourrain P. Endogenous retinal neural stem cell reprogramming for neuronal regeneration. Neural Regen Res. 2017;12(11):1765–1767. doi:10.4103/1673-5374.219028
   PubMed Web of Science ®Google Scholar
• Bai C, Li X, Gao Y, et al. Melatonin improves reprogramming efficiency and proliferation of bovine-induced pluripotent stem cells. J Pineal Res. 2016;61(2):154–167. doi:10.1111/jpi.12334
   PubMed Web of Science ®Google Scholar
• Gao Y, Ma L, Bai C, Zhang X, Yang W. Melatonin promotes self-renewal and nestin expression in neural stem cells from the retina. Histol Histopathol. 2019;34(6):645–654. doi:10.14670/hh-18-065
   PubMed Web of Science ®Google Scholar
• Ping Z, Hu X, Wang L, et al. Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/β-catenin signaling pathway. Acta Biomater. 2017;51:513–525. doi:10.1016/j.actbio.2017.01.034
   PubMed Web of Science ®Google Scholar
• Giannaccare G, Carnevali A, Senni C, Logozzo L, Scorcia V. Umbilical cord blood and serum for the treatment of ocular diseases: a comprehensive review. Ophthalmol Ther. 2020;9(2):235–248. doi:10.1007/s40123-020-00239-9
   PubMed Web of Science ®Google Scholar
• Yi C, Pan X, Yan H, Guo M, Pierpaoli W. Effects of melatonin in age-related macular degeneration. Ann N Y Acad Sci. 2005;1057:384–392. doi:10.1196/annals.1356.029
   PubMed Web of Science ®Google Scholar
• Harpsøe NG, Andersen LP, Gögenur I, Rosenberg J. Clinical pharmacokinetics of melatonin: a systematic review. Eur J Clin Pharmacol. 2015;71(8):901–909. doi:10.1007/s00228-015-1873-4
   PubMed Web of Science ®Google Scholar
• Seiden DJ, Shah SM. A randomized, crossover, pharmacokinetics evaluation of a novel continuous release and absorption melatonin formulation. Prim Care Companion CNS Disord. 2019;21(4). doi:10.4088/PCC.19m02450
   PubMedGoogle Scholar
• Dal Monte M, Cammalleri M, Amato R, et al. A topical formulation of melatoninergic compounds exerts strong hypotensive and neuroprotective effects in a rat model of hypertensive glaucoma. Int J Mol Sci. 2020;21(23). doi:10.3390/ijms21239267
   PubMed Web of Science ®Google Scholar
• Tao Y, Hu B, Ma Z, et al. Intravitreous delivery of melatonin affects the retinal neuron survival and visual signal transmission: in vivo and ex vivo study. Drug Deliv. 2020;27(1):1386–1396. doi:10.1080/10717544.2020.1818882
   PubMed Web of Science ®Google Scholar
• Yu H, Wu W, Lin X, Feng Y. Polysaccharide-based nanomaterials for ocular drug delivery: a perspective. Front Bioeng Biotechnol. 2020;8:601246. doi:10.3389/fbioe.2020.601246
   PubMed Web of Science ®Google Scholar
• Ahn JH, Kim HD, Abuzar SM, et al. Intracorneal melatonin delivery using 2-hydroxypropyl-β-cyclodextrin ophthalmic solution for granular corneal dystrophy type 2. Int J Pharm. 2017;529(1–2):608–616. doi:10.1016/j.ijpharm.2017.07.016
   PubMedGoogle Scholar
• Musumeci T, Bucolo C, Carbone C, Pignatello R, Drago F, Puglisi G. Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits. Int J Pharm. 2013;440(2):135–140. doi:10.1016/j.ijpharm.2012.10.014
   PubMed Web of Science ®Google Scholar
• Carbone C, Manno D, Serra A, et al. Innovative hybrid vs polymeric nanocapsules: the influence of the cationic lipid coating on the ”4S”. Colloids Surf B Biointerfaces. 2016;141:450–457. doi:10.1016/j.colsurfb.2016.02.002
   PubMed Web of Science ®Google Scholar
• Bessone CDV, Martinez SM, Luna JD, et al. Neuroprotective effect of melatonin loaded in ethylcellulose nanoparticles applied topically in a retinal degeneration model in rabbits. Exp Eye Res. 2020;200:108222. doi:10.1016/j.exer.2020.108222
   PubMed Web of Science ®Google Scholar
• Arranz-Romera A, Davis BM, Bravo-Osuna I, et al. Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma. J Control Release. 2019;297:26–38. doi:10.1016/j.jconrel.2019.01.012
   PubMed Web of Science ®Google Scholar